Current Report Filing (8-k)
January 17 2019 - 4:47PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or Section 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
January 11, 2019
SPHERIX INCORPORATED
(Exact name of registrant as specified in its
charter)
Delaware
|
000-05576
|
52-0849320
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
One Rockefeller Plaza
New York, NY 10020
|
10020
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including
area code:
(212) 745-1374
(Former name or former address, if changed since
last report)
Check the appropriate box below if
the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following
provisions:
|
[_]
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
[_]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
[_]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
[_]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
[X]
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
[_]
|
Item 3.01
|
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of
Listing.
|
On January 11, 2019, Spherix
Incorporated (the “
Company
”) received written notice (the “
Notice
”) from the Listing Qualifications
Department (the “
Staff
”) of The NASDAQ Stock Market LLC (“
Nasdaq
”) indicating that, based
upon the Company’s non-compliance with Nasdaq Listing Rule 5620(a), which requires an issuer to hold an annual meeting of
shareholders no later than one year after the end of the Company's fiscal year-end (the “
Annual Meeting Rule
”),
the Company would be required to submit a plan to regain compliance with the Annual Meeting Rule for the Staff’s consideration
by no later than February 25, 2019. The Notice has no immediate impact on the Company’s listing or trading in the Company’s
securities on Nasdaq.
The
Company intends to timely submit a compliance plan for the Staff’s review. If the Staff accepts the plan, the Staff may grant
the Company an extension of up to 180 calendar days from the Company’s fiscal year end, through July 1, 2019, to evidence
compliance with the Annual Meeting Rule. If the Staff does not accept the Company’s plan, the Company would be entitled to
request a hearing, at which hearing it would present its plan to a Nasdaq Hearings Panel and request the continued listing of its
securities on Nasdaq pursuant to and pending the completion of such plan. During the pendency of the hearing process, the Company’s
securities would continue to be listed on Nasdaq.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: January 17, 2019
SPHERIX INCORPORATED
By:
/s/ Anthony Hayes
Name: Anthony Hayes
Title: President and Chief Executive Officer
Alkido Pharma (NASDAQ:AIKI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alkido Pharma (NASDAQ:AIKI)
Historical Stock Chart
From Apr 2023 to Apr 2024